Heron Therapeutics, Inc. (HRTX): Price and Financial Metrics
Heron Therapeutics, Inc. (HRTX)
Today's Latest Price: $17.40 USD
Updated Dec 3 12:53pm
Add HRTX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
HRTX Stock Summary
- HRTX's went public 33.29 years ago, making it older than 91.74% of listed US stocks we're tracking.
- For HRTX, its debt to operating expenses ratio is greater than that reported by just 10.79% of US equities we're observing.
- HRTX's price/sales ratio is 15.45; that's higher than the P/S ratio of 89.72% of US stocks.
- If you're looking for stocks that are quantitatively similar to Heron Therapeutics Inc, a group of peers worth examining would be FREQ, BLUE, APTX, RESN, and MYOV.
- HRTX's SEC filings can be seen here. And to visit Heron Therapeutics Inc's official web site, go to www.herontx.com.
HRTX Stock Price Chart Interactive Chart >
HRTX Price/Volume Stats
| Current price | $17.40 | 52-week high | $26.81 |
| Prev. close | $17.54 | 52-week low | $9.60 |
| Day low | $17.22 | Volume | 253,348 |
| Day high | $17.57 | Avg. volume | 1,141,643 |
| 50-day MA | $16.43 | Dividend yield | N/A |
| 200-day MA | $15.96 | Market Cap | 1.58B |
Heron Therapeutics, Inc. (HRTX) Company Bio
Heron Therapeutics is a biotechnology company focused on improving the lives of patients by developing best-in-class medicines that address major unmet medical needs. The company was founded in 1983 and is based in Redwood City, CA.
Loading social stream, please wait...